A Simple Colonoscopy Can Save Your Life

Health & Lifestyle
341

Translate to Spanish or other 102 languages!

A routine screening for colorectal cancer beginning at age 45 can save lives! Image for illustration purposes
A routine screening for colorectal cancer beginning at age 45 can save lives! Image for illustration purposes

Mega Doctor News

- Advertisement -

By Texas Tech University Health Sciences Center El Paso

Newswise — A routine screening for colorectal cancer beginning at age 45 can save lives! In cancers that affect both men and women, colorectal cancer is the second leading cancer killer—but most cases can be prevented with routine screening tests.

Colorectal cancer usually starts from precancerous polyps in the colon or rectum. Over time, some polyps can turn into cancer.

- Advertisement -

Screening tests aid in finding precancerous polyps, so they can be removed before they turn into cancer. Screening tests can also find colorectal cancer early, when treatment works best.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Nursing Grad Gets a Life Lesson In Compassion
Next article
Let The Patient Choose Their Type 2 Diabetes Meds

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -